Skip to main content

Featured

Trump Pushes Iran Strike Deadline Into April Amid Intensifying Regional Tensions

Onlookers watch from a window the site of a residential building damaged by a strike, amid the U.S.-Israeli conflict with Iran, in Tehran, Iran, March 27, 2026.  U.S. President Donald Trump has extended the deadline for Iran to reopen the Strait of Hormuz or face strikes on its energy infrastructure, moving the cutoff to April 6 at 8 p.m. EDT (April 7 GMT) . The decision follows Tehran’s rejection of a 15‑point U.S. proposal aimed at ending the conflict, which has already spread across the Middle East and disrupted global energy markets.  The conflict, now in its fourth week, has resulted in thousands of casualties and sent oil and fertilizer prices soaring, fueling global inflation concerns. The United States and Israel began striking Iranian targets on February 28 after nuclear negotiations failed to produce a deal. Trump stated that talks are “going very well,” though Iran denies any direct engagement with Washington.  Trump’s extension comes after he previously pau...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment